The risk of hypoglycemic complications in PTDM patients was found to be comparable to other types of DM [29], and basal insulin treatment can negatively affect HRQOL by inducing symptomatic albeit mild hypoglycemia [30]. This evidence concerns the gene INS and Hypoglycemia.